Like in Ewing sarcoma, nonenzymatic LSD1 activity is likely important in this tumor, as Romo-Morales et al., provide evidence that solely catalytic inhibition with irreversible inhibitors of LSD1 shows no antitumor activity (63). The gene discussed is KDM1A; the disease is neoplasm.